Gender Male
Roger received his Ph.D. from the University of Texas in Biomedical Sciences, with a concentration in Experimental Pathology (Oncology). A Board Certified Cardiovascular Perfusionist, Roger has applied this clinical expertise to over 30 years of research in whole-body hyperthermia. With numerous scientific publications, Roger has pioneered the
industry of effective whole-body hyperthermia including its application in pre-clinical animal studies and as well as the only human trials of lung and ovarian cancer patients. Roger is co-inventor of the CoreHFC™ device.
